13F Pro Quality Score

49.5/100

Rank #1,504 of 2,879 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

74.1/100

Profitability

35.9/100

Balance Sheet

45.7/100

Earnings Quality

13.4/100

Free Cash Flow

60.1/100

Institutional Flow

88.9/100

Revenue Scale

30.0/100

Dilution Risk

39.1/100

TRNS Stock Analysis & AI Quality Score

AI stock analysis and institutional research for TRANSCAT INC (TRNS), a Technology sector company. 13F Pro's AI-powered ranking engine scores TRNS at 49.5/100 on a 32-signal composite quality model, placing it at rank #1,504 of 2,879 stocks — the bottom half of the AI-ranked universe. TRNS scores in the top quartile across institutional flow (88.9). Areas of concern include earnings quality (13.4) and revenue scale (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 39.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2026), TRANSCAT INC reports quarterly revenue of $89.3M, net income of $1.9M, an operating margin of 4.9%. Top institutional holders of TRNS by reported 13-F value include Neuberger Berman Group, BlackRock,, Hood River Capital Management, based on the most recent SEC filings. TRNS trades on the Nasdaq exchange and files with the SEC under CIK 99302. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TRNS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TRANSCAT INC directly from SEC EDGAR. TRANSCAT INC's 13F Pro composite quality score has ranged between 8 and 75 since 2021, currently 49.5 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about TRANSCAT INC

Quirks, history, and lore behind TRNS — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. technology services company · small-cap · listed on Nasdaq · headquartered in upstate New York.
  • 2
    The Numbers
    Annual revenue in the range of $250–300 million — not flashy, but it's carved out a niche leadership position in a highly specialized market most investors have never heard of.
  • 3
    The History
    Founded in the 1960s, it has spent decades building out a national network of labs and distribution branches serving industrial and technical customers across North America.
  • 4
    The Secret
    Its core business is calibration services — making sure that measuring instruments actually measure correctly — which sounds unglamorous until you realize virtually every factory and lab needs it.
  • 5
    The Lore
    It's one of the largest third-party calibration providers in North America, also selling and renting test and measurement equipment from major instrument brands.
  • 6
    The Giveaway
    When your torque wrench, pressure gauge, or electrical test instrument needs to be certified accurate, this Rochester-based metrology specialist is who industry calls.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q4 2026

$89.3M

Net Income

Q4 2026

$1.9M

Free Cash Flow

Q4 2026

$2.6M

Operating Margin

Q4 2026

4.9%

ROIC

Q4 2026

1.1%

D/E Ratio

Q4 2026

0.33

AI Insight: TRNS Financial Trends

Revenue grew 33% from Q2 2024 to Q1 2026, but profitability collapsed and debt surged 25x, signaling acquisition-driven growth masking operational strain.

Revenue accelerated from $67M (Q2 2024) to $89M (Q1 2026), a 33% gain over eight quarters.

Net income declined from $4M (Q2 2024) to $2M (Q1 2026); Q4 2025 posted -$1M loss despite $84M revenue.

Total debt surged from $4M (Q2 2024) to $100M (Q1 2026); debt-to-equity ratio jumped from 1.5% to 33%.

Operating margin has compressed sharply: 7.5% (Q2 2024) to near-zero 4.5% (Q1 2026) despite revenue growth.

Operating cash flow deteriorated to $6M (Q1 2026), lowest in eight quarters, amid heavy debt burden.

Q3 2025 debt spike to $112M suggests major acquisition; debt remains elevated with no clear deleveraging path.

Get alerted when TRNS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for TRANSCAT INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put TRNS on your watchlist

Track score changes the day TRANSCAT INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is TRNS a good stock to buy?

13F Pro's AI-powered analysis of TRANSCAT INC (TRNS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TRNS are available on the TRNS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own TRNS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TRNS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TRANSCAT INC's investment landscape.